Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations

Breadcrumb

  1. Emmes Group

Easy-to-read informed consent forms for hematopoietic cell transplantation clinical trials.

Go back to Resources

Easy-to-read informed consent forms for hematopoietic cell transplantation clinical trials.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Treatment of geographic atrophy with subconjunctival sirolimus: results of a phase I/II clinical trial.

Go back to Resources

Treatment of geographic atrophy with subconjunctival sirolimus: results of a phase I/II clinical trial.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

The natural history of milk allergy in an observational cohort.

Go back to Resources

The natural history of milk allergy in an observational cohort.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Score Study Report 12: Development of venous collaterals in the Score Study.

Go back to Resources

Score Study Report 12: Development of venous collaterals in the Score Study.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Safety and immunological outcomes following human inoculation with nontypeable Haemophilus influenzae.

Go back to Resources

Safety and immunological outcomes following human inoculation with nontypeable Haemophilus influenzae.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Response to commentaries.

Go back to Resources

Response to commentaries.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Go back to Resources

Early-phase clinical trials in the community: results from the national cancer institute community cancer centers program early-phase working group baseline assessment.

Go back to Resources

Early-phase clinical trials in the community: results from the national cancer institute community cancer centers program early-phase working group baseline assessment.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys.

Go back to Resources

Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes.

Go back to Resources

Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Phase II trial of parathyroid hormone after double umbilical cord blood transplantation.

Go back to Resources

Phase II trial of parathyroid hormone after double umbilical cord blood transplantation.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 69
  • Page 70
  • Page 71
  • Page 72
  • Current page 73
  • Page 74
  • Page 75
  • Page 76
  • Page 77
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • Terms of Use
  • ISO Certification